LDL-Apheresis Up-Regulates VEGF and IGF-I in Patients With Ischemic Limb

Journal of Clinical Apheresis

Volumn 18, Issue 3, 2003, Pages 115-119

  Kobayashi, Shuzo ^a   Moriya, Hidekazu ^a   Negishi, Kousuke ^a   Maesato, Kyouko ^a   Ohtake, Takayasu ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Fibrinogen; Insulin like growth factor I (IGF I); LDL apheresis; Peripheral arterial occlusive disease (PAOD); Vascular endothelial growth factor (VEGF)

Indexed keywords

LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C; VASCULOTROPIN;

ADULT; AGED; APHERESIS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BLOOD COMPONENT REMOVAL; EXTREMITIES; FEMALE; FIBRINOGEN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0142103707     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10055     Document Type: Article

References (31)

1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
2. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-621.
3. Saal SD, Parker TS, Gordon BR, Studebaker J, Hudgins L, Ahrens EH Jr, Rubin AL. Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption. Am J Med 1986;80:583-589.
4. Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael MJ, Steiner RE. Assessment of long-term plasma-exchange for familial hypercholesteromia. Br Heart J 1980;43:680-690.
5. Rubba P, Postiglione A, Scarpato N, Iannuzzi A, Mancini M. Improved reactive hyperemia test after plasma exchange in familial hypercholesteromia. Atherosclerosis 1985;56:237-242.
6. Agishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H. Improvement of peripheral circulation by low density lipoprotein adsorption. Asaio Trans 1989:35;349-351.
7. Agishi T, Naganuma S, Nakasato S, Kitajima K, Ota K, Ban K. Treatment of arteriosclerotic obstruction by LDL adsorption. Angiology 1993;44:222-227.
8. Kroon AA, Aengevaeren WR, van der Werf T, Uijen GJ, Reiber JH, Bruschke AV, Stalenhoef AF. The LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-1835.
9. Kobayashi S. LDL-apheresis for diabetic nephropathy: a possible new tool. Nephron 1998;79:505-506.
10. Mii S, Mori A, Sakata H, Nakayama M, Tsuruta H. LDL-apheresis for arteriosclerosis obliterans with occluded bypass graft: Change in prostacyclin and effect on ischemic syndrome. Angiology 1998;49:175-180.
11. Koenig W, Ditschuneit HH, Grunewald RW, Ernst E, Hombach V. Blood rheology after apheresis using dextran sulfate cellulose absorption: a case report. Angiology 1992;43:606-609.
12. Naganuma S, Agishi T, Ota K. Effect of LDL-aphereis on lipoprotein (a) levels in arteriosclerotic obliterans. Artif Org 1991;15:336-339.
13. Murashima J, Ueki Y, Matsunaga Y, Yano M, Matsumoto K, Miyake S, Tominaga Y, Eguchi K, Yano K. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis. Blood Coag Fibrinol 1998;9:725-732.
14. Uno H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K, Yano K. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterans. Atherosclerosis 1995;116:93-102.
15. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
16. Kojima S, Shida M, Tanaka K, Takano H, Yokoyama H, Kuramochi M. Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis. Therapeut Apheresis 2001;5:2-6.
17. Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 2001;106:148-156.
18. Zapf J, Froesch ER. Insulin-like growth factor/somatomedins: structures, secretion, biological actions and physiological role. Horm Res 1986;24:121-130.
19. Hansson H, Jennische E, Skottner A. Regenerating endothelial cells express insulin-like growth factor-I immunoreactivity after arterial injury. Cell Tissue Res 1987;250:499-505.
20. Yamamoto A, Yokoyama S, Satani M, Kikkawa T, Kishiomoto B. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system. Prog Clin Biol Res 1988;255:357-366.
21. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
22. Ferrara N: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999;56:794-814.
23. Aicllo LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen H, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
24. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999;5:1359-1364.
25. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
26. 165 in patient with ischemic limb. Lancet 1996;348:370-374.
27. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994;45:598-604.
28. Knisel W, Di Nicuolo A, Pfohl M, Müller H, Risler T, Eggstein M, Seifried E. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Int Med 1993;234:479-487.
29. Merril EW. Rheology of blood: the increase of viscosity correlating with increased fibrinogen levels in patients with intermittent claudication. Physiol Rev 1969;49:863-866.
30. Ward AS, Porter N, Preston FE. Platelet aggregation in patients with peripheral arterial disease. Atherosclerosis 1978;29:63-68.
31. Tsusima N, Matsuo H, Hayashi T, Homma A. The clinical features and treatment of arteriosclerosis obliterans with diabetes. Diabetes 1996;45(Suppl 3):S101-S104.